Insider · CIK 0001724195

Sabzevari Helen

Reports to the SEC for 2 companies · GERMANTOWN, MD

sec.gov

Transactions

Companies

Filings

CIK

0001724195

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-23	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+20.8K sh	—	—	3,789,705
2026-08-23	PGENPRECIGEN, INC.F Tax Payment	President and CEO	FTax Payment	−10.2K sh	$7.20	−$73.3K	3,779,521
2026-08-23	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−20.8K sh	—	—	229,167
2026-06-29	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+347K sh	$2.33	+$808K	4,115,708
2026-06-29	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−347K sh	$5.89	−$2.04M	3,768,872
2026-06-29	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)M Exercise/Conversion	President and CEO	MExercise/Conversion	−347K sh	—	—	500,164
2026-05-28	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−119K sh	$4.36	−$520K	3,768,872
2026-05-23	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+250K sh	—	—	3,888,122
2026-05-23	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−250K sh	—	—	250,000
2026-04-20	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President and CEO	AAward	+1.37M sh	—	—	1,366,000
2026-04-20	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+410K sh	—	—	410,000
2026-03-18	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+321K sh	—	—	3,638,122
2026-03-18	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+321K sh	—	—	321,100
2026-03-18	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−321K sh	—	—	0
2025-09-12	PGENPRECIGEN, INC. · Performance Stock UnitsA Award	President and CEO	AAward	+825K sh	—	—	825,000
2025-06-26	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+500K sh	—	—	500,000
2025-05-23	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President and CEO	AAward	+1M sh	—	—	1,000,000
2025-05-16	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+1.08M sh	—	—	3,838,246
2025-05-16	PGENPRECIGEN, INC.F Tax Payment	President and CEO	FTax Payment	−521K sh	$1.45	−$756K	3,317,022
2025-05-16	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−1.08M sh	—	—	0
2025-04-17	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+1.08M sh	—	—	1,079,137
2025-01-29	PGENPRECIGEN, INC.A Award	President and CEO	AAward	+825K sh	—	—	3,046,076
2025-01-29	PGENPRECIGEN, INC.F Tax Payment	President and CEO	FTax Payment	−287K sh	$1.30	−$373K	2,759,109
2024-05-31	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President and CEO	AAward	+1.8M sh	—	—	1,803,000
2024-04-05	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+1.07M sh	—	—	2,631,433
2024-04-05	PGENPRECIGEN, INC.F Tax Payment	President and CEO	FTax Payment	−410K sh	$1.40	−$574K	2,221,076
2024-04-05	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+1.07M sh	—	—	1,071,429
2024-04-05	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−1.07M sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40.5K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.3K sh	—	—	0
2023-08-25	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−77K sh	$1.53	−$118K	1,560,004
2023-08-23	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+142K sh	—	—	1,636,973
2023-08-23	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−142K sh	—	—	0
2023-08-18	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−55.9K sh	$1.66	−$92.7K	1,495,386
2023-08-16	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+142K sh	—	—	1,551,241
2023-08-16	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−142K sh	—	—	141,587
2023-08-11	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−41.4K sh	$1.44	−$59.7K	1,409,654
2023-08-09	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+142K sh	—	—	1,451,090
2023-08-09	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−142K sh	—	—	283,173
2023-08-04	PGENPRECIGEN, INC.S Sale	President and CEO	SSale	−52.9K sh	$1.10	−$58.2K	1,309,503
2023-08-02	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+142K sh	—	—	1,362,373
2023-08-02	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−142K sh	—	—	424,760
2023-06-12	Kinnate Biopharma Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-04-28	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President and CEO	AAward	+1.73M sh	—	—	1,732,300
2023-03-24	PGENPRECIGEN, INC.M Exercise/Conversion	President and CEO	MExercise/Conversion	+283K sh	—	—	1,220,786
2023-03-24	PGENPRECIGEN, INC. · Restricted Stock UnitsA Award	President and CEO	AAward	+850K sh	—	—	849,520
2023-03-24	PGENPRECIGEN, INC. · Restricted Stock UnitsM Exercise/Conversion	President and CEO	MExercise/Conversion	−283K sh	—	—	566,347
2023-03-24	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)A Award	President and CEO	AAward	+370K sh	—	—	369,596
2023-01-27	PGENPRECIGEN, INC.P Purchase	President and CEO	PPurchase	+22.9K sh	$1.75	+$40K	937,613

Recent filings

Accepted (ET)
Aug 254
Sabzevari Helen0000950103-26-012870
SEC(opens sec.gov)
Jul 14
Sabzevari Helen0000950103-26-009978
SEC(opens sec.gov)
Jun 14
Sabzevari Helen0000950103-26-008168
SEC(opens sec.gov)
May 274
Sabzevari Helen0000950103-26-007842
SEC(opens sec.gov)
Apr 224
Sabzevari Helen0000950103-26-006044
SEC(opens sec.gov)
Mar 204
Sabzevari Helen0000950103-26-004489
SEC(opens sec.gov)
Sep 164
Sabzevari Helen0000950103-25-011726
SEC(opens sec.gov)
Jun 274
Sabzevari Helen0000950103-25-007990
SEC(opens sec.gov)
May 274
Sabzevari Helen0000950103-25-006450
SEC(opens sec.gov)
May 164
Sabzevari Helen0000950103-25-006143
SEC(opens sec.gov)

Companies

Address

20374 SENECA MEADOWS PARKWAY

GERMANTOWN, MD, 20876